Philip C. Hoffman

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Karen Kelly, Nasser K. Altorki, Wilfried Eberhardt et al. · Journal of Clinical Oncology · 2015 · 485 citations · Full text

Medicine, Oncology, Pharmacology +14

Stereotactic body radiotherapy for multisite extracranial oligometastases

Joseph K. Salama, Michael D. Hasselle, Steven J. Chmura et al. · Cancer · 2011 · 323 citations

Medicine, Oncology, Radiation Oncology +17

Phase I Study of G3139, a <i>bcl-2</i> Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Charles M. Rudin, Mark Kozloff, Philip C. Hoffman et al. · Journal of Clinical Oncology · 2004 · 166 citations · Full text

Medicine, Oncology, Pharmacology +15

Supporting family conversations and children's STEM learning in a children's museum

Catherıne A. Haden, Erin A. Jant, Philip C. Hoffman et al. · Early Childhood Research Quarterly · 2014 · 156 citations

Education, Early Childhood Education, Science Education +14

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison et al. · Journal of Thoracic Oncology · 2021 · 141 citations

Medicine, Oncology, Radiation Oncology +11